- Home
- CUE vs CFSB Comparison
CUE vs CFSB Comparison
Compare CUE & CFSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUE
- CFSB
- Stock Information
- Founded
- CUE 2014
- CFSB 1889
- Country
- CUE United States
- CFSB United States
- Employees
- CUE N/A
- CFSB N/A
- Industry
- CUE Biotechnology: Pharmaceutical Preparations
- CFSB Major Banks
- Sector
- CUE Health Care
- CFSB Finance
- Exchange
- CUE Nasdaq
- CFSB Nasdaq
- Market Cap
- CUE 48.0M
- CFSB 51.6M
- IPO Year
- CUE 2018
- CFSB N/A
- Fundamental
- Price
- CUE $0.70
- CFSB $13.70
- Analyst Decision
- CUE Strong Buy
- CFSB
- Analyst Count
- CUE 3
- CFSB 0
- Target Price
- CUE $3.00
- CFSB N/A
- AVG Volume (30 Days)
- CUE 220.4K
- CFSB 18.7K
- Earning Date
- CUE 08-13-2025
- CFSB 07-29-2025
- Dividend Yield
- CUE N/A
- CFSB N/A
- EPS Growth
- CUE N/A
- CFSB N/A
- EPS
- CUE N/A
- CFSB N/A
- Revenue
- CUE $7,991,000.00
- CFSB $7,484,000.00
- Revenue This Year
- CUE N/A
- CFSB N/A
- Revenue Next Year
- CUE $23.84
- CFSB N/A
- P/E Ratio
- CUE N/A
- CFSB N/A
- Revenue Growth
- CUE 13.83
- CFSB N/A
- 52 Week Low
- CUE $0.45
- CFSB $6.34
- 52 Week High
- CUE $1.99
- CFSB $13.78
- Technical
- Relative Strength Index (RSI)
- CUE 55.84
- CFSB 89.63
- Support Level
- CUE $0.54
- CFSB $13.68
- Resistance Level
- CUE $0.66
- CFSB $13.70
- Average True Range (ATR)
- CUE 0.06
- CFSB 0.03
- MACD
- CUE 0.01
- CFSB -0.19
- Stochastic Oscillator
- CUE 81.98
- CFSB 100.00
About CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.
About CFSB CFSB Bancorp Inc.
CFSB Bancorp Inc provides banking services. It offers a variety of financial services to individuals and small businesses through its offices in Quincy, Holbrook, and Weymouth. Its primary deposit products are savings, checking, and term certificate accounts, and its primary lending product is residential mortgage loans.The Company's loan portfolio includes residential real estate, commercial real estate, construction, and consumer loan segments. Residential real estate loans include classes for one- to four-family, multi-family, second mortgages and home equity lines of credit.